MX2018011201A - Oclusion de fuga de liquido cefalorraquideo. - Google Patents

Oclusion de fuga de liquido cefalorraquideo.

Info

Publication number
MX2018011201A
MX2018011201A MX2018011201A MX2018011201A MX2018011201A MX 2018011201 A MX2018011201 A MX 2018011201A MX 2018011201 A MX2018011201 A MX 2018011201A MX 2018011201 A MX2018011201 A MX 2018011201A MX 2018011201 A MX2018011201 A MX 2018011201A
Authority
MX
Mexico
Prior art keywords
cerebrospinal fluid
fluid leakage
self
assembling peptide
treating
Prior art date
Application number
MX2018011201A
Other languages
English (en)
Spanish (es)
Inventor
Kobayashi Satoru
Original Assignee
3 D Matrix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3 D Matrix Ltd filed Critical 3 D Matrix Ltd
Publication of MX2018011201A publication Critical patent/MX2018011201A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
MX2018011201A 2016-03-18 2017-03-17 Oclusion de fuga de liquido cefalorraquideo. MX2018011201A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662310122P 2016-03-18 2016-03-18
PCT/IB2017/000387 WO2017158435A1 (en) 2016-03-18 2017-03-17 Cerebrospinal fluid leakage occlusion

Publications (1)

Publication Number Publication Date
MX2018011201A true MX2018011201A (es) 2018-11-22

Family

ID=58645333

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018011201A MX2018011201A (es) 2016-03-18 2017-03-17 Oclusion de fuga de liquido cefalorraquideo.

Country Status (9)

Country Link
US (1) US20210023257A1 (cg-RX-API-DMAC7.html)
EP (1) EP3429645A1 (cg-RX-API-DMAC7.html)
JP (1) JP2019508181A (cg-RX-API-DMAC7.html)
CN (1) CN109195640A (cg-RX-API-DMAC7.html)
AU (1) AU2017232550A1 (cg-RX-API-DMAC7.html)
BR (1) BR112018068939A2 (cg-RX-API-DMAC7.html)
CL (1) CL2018002643A1 (cg-RX-API-DMAC7.html)
MX (1) MX2018011201A (cg-RX-API-DMAC7.html)
WO (1) WO2017158435A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112018068941A2 (pt) 2016-03-18 2019-04-16 3-D Matrix, Ltd. prevenção de adesão de tecidos biológicos
CN115397454A (zh) 2020-03-31 2022-11-25 立美基股份有限公司 通过辐照对自组装肽进行灭菌

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1879606T3 (da) * 2005-04-25 2013-09-23 Massachusetts Inst Technology Selvorganiserende peptider til fremme af hæmostase
US9162005B2 (en) * 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
US7854923B2 (en) * 2006-04-18 2010-12-21 Endomedix, Inc. Biopolymer system for tissue sealing
ES2673947T3 (es) * 2006-04-25 2018-06-26 Massachusetts Institute Of Technology Composiciones y métodos para afectar al movimiento de contaminantes, líquidos corporales u otras entidades y/o afectar a otras condiciones fisiológicas
RU2011118341A (ru) * 2008-10-06 2012-11-20 3-Д Матрикс, Лтд. (Jp) Агент для окклюзии тканей
CN103800941B (zh) * 2012-11-09 2015-04-22 北京银河巴马生物技术股份有限公司 一种i型胶原材料、脑膜或脊膜生物膜片及其制备方法和应用
US20160287744A1 (en) * 2012-11-14 2016-10-06 3-D Matrix Ltd. Vascular embolic system
HK1220145A1 (zh) * 2013-03-14 2017-04-28 3-D Matrix, Ltd 胆漏治疗

Also Published As

Publication number Publication date
JP2019508181A (ja) 2019-03-28
CN109195640A (zh) 2019-01-11
WO2017158435A1 (en) 2017-09-21
EP3429645A1 (en) 2019-01-23
BR112018068939A2 (pt) 2019-01-22
CL2018002643A1 (es) 2019-04-26
AU2017232550A1 (en) 2018-09-27
US20210023257A1 (en) 2021-01-28

Similar Documents

Publication Publication Date Title
MX2018011120A (es) Oclusion de fistula pancreatica.
PH12020500321A1 (en) Amino acid compositions for the treatment of liver disease
EA201791775A1 (ru) Цистеиновая протеаза
HK1220145A1 (zh) 胆漏治疗
EA201791747A1 (ru) 3-алкил-4-амидобициклические [4,5,0] гидроксамовые кислоты в качестве ингибиторов hdac
AR088044A1 (es) Proteinas de fusion para tratar trastornos metabolicos
CY1122899T1 (el) Υδατικη συσταση περιλαμβανουσα παρακεταμολη και ιβουπροφαινη
WO2016112208A3 (en) Topical applications of kv1.3 channel blocking peptides to treat skin inflammation
EA201791537A1 (ru) Фармацевтическая композиция на основе наночастиц доцетаксела-альбумина, способ ее получения и ее применение
EP3768266A4 (en) OXO-TETRAHYDRO-ISOCHINOLINE-CARBOXYLIC ACIDS AS STING INHIBITORS
MX2019001633A (es) Proteina derivada de la seda para el tratamiento de la inflamacion.
WO2018108991A3 (en) Methods of treating amyloid-beta peptide diseases
EP4072483A4 (en) Systems and devices for delivering fluids to the eye and methods of use
PE20160012A1 (es) Tratamiento de enfermedades miopaticas y neurogenerativas por agregacion de proteina mediante administracion parenteral
MX380968B (es) Angiotensina ii sola o en combinacion para usarse en el tratamiento de hipotension.
AU2017310412A8 (en) Method of improving connective tissue attachment using anti-sclerostin antibodies
PH12017501304A1 (en) Levodopa and carbidopa intestinal gel and method of use
WO2019043649A3 (en) ANGIO -3 FOR THE TREATMENT OF RETINAL ANGIOGENIC DISEASES
MX2018011121A (es) Prevención de la adherencia de tejido biológico.
MX2018011201A (es) Oclusion de fuga de liquido cefalorraquideo.
EA201892320A1 (ru) Способ лечения или предупреждения остеоартрита
MX2018011082A (es) Péptido o aminoácido n-lipoico, derivados y sus usos.
MX2020007222A (es) Metodos para el tratamiento de afecciones inflamatorias de la piel.
EA201500765A1 (ru) Способы лечения сердечно-сосудистых заболеваний
MX381978B (es) Composición de inmunoglobulina de alta concentración para aplicación farmacéutica.